The Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. are proud to present the "Hepatitis Grand Rounds" 2019 series. Formerly the "Viral Hepatitis Grand Rounds", this program is modeled on the ground-breaking CME activity "HIV Grand Rounds," which, in partnership with the Perelman School of Medicine at the University of Pennsylvania, is currently in its tenth year. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The  Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is delivered live via the Internet on two Wednesdays each month at 12:00 pm Eastern Time and each presentation is available for on-demand viewing immediately following the live broadcast.

Hepatitis Grand Rounds presentations cover the most important and current topics in hepatitis, including NASH, HBV and HCV, and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These bi-monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their hepatitis patients. 

TARGET AUDIENCE:

This program has been designed for Family Medicine, Pediatrics, Neurology, Obstetrics And Gynecology, Psychiatry, Internal Medicine - Endocrinology, Diabetes And Metabolism, Internal Medicine - Gastroenterology, Internal Medicine - Infectious Disease, Internal Medicine - Transplant Hepatology

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT:

Gilead Sciences Medical Affairs.

SERIES EDUCATIONAL OBJECTIVES:

After participating in this regularly scheduled series, participants should be able to:

• Demonstrate increased understanding of the epidemiology of and risk factors for viral hepatitis and NASH
• Increase the rate of testing of viruses and other conditions associated with hepatitis, such as NASH 
• Demonstrate improved knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral and non-viral hepatitis, including those with NASH
• Demonstrate an improved understanding of the treatment of hepatitis in patients co-infected with HIV or other viral infections

SESSION EDUCATIONAL OBJECTIVES:

After participating in this regularly scheduled series, participants should be able to:

• Discuss limitations of non-invasive assessment of fibrosis in NAFLD/NASH
  Review role of surgical and endobariatric weight loss in NAFLD/NASH

PROGRAM FACULTY:

 

	David Kaplan, MD Associate Professor of Medicine Division of Gastroenterology University of Pennsylvania Philadelphia, Pennsylvania
	Raymond Soccio, MD Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism University of Pennsylvania Philadelphia, Pennsylvania

 

ACCREDITATION:

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

DESIGNATION OF CREDIT:

Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit^TM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS AND UNAPPROVED USES OF PRODUCTS:

It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE)  have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

• Program Co-Chairs: K. Rajender Reddy, MD; Raymond Soccio, MD
• ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon
• Presenter: Raymond Soccio, MD